JPRN-UMIN000043378已完成未知
sefulness of monitoring sunitinib plasma concentration for the patients with metastatic renal cell carcinoma - Monitoring for plasma concentration of sunitinib
agasaki University0 个研究点目标入组 64 人开始时间: 2021年2月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 64
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 with liver and/or renal dysfunction (over ULNx2) 2 with severe heart failure
研究者
相似试验
已完成
不适用
The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal CancerKidney NeoplasmsNCT02404584Centre Hospitalier Universitaire de Nīmes43
招募中
不适用
Safety and Efficacy of Sunitinib Given in Schedule Modification in Patients with Advanced Renal Cell Carcinoma (RCC)Renal Cell CarcinomaJPRN-UMIN000011649Osaka University Graduate School of Medicine132
尚未招募
2 期
Improving sunitinib efficacy and tolerability in patients with metastatic clear cell carcinoma of the kidney by using a 14/7 day schedule and toxicity-adjusted dosingMetastatic Renal Cell CancerCancer - KidneyACTRN12616001639415Macquarie University80
已完成
1 期
Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyNon GIST SarcomasNCT01308034Centre Leon Berard25
已完成
1 期
Study Of SU011248 Plus Gefitinib (Iressa) In Patients With Advanced Renal Cell CarcinomaCarcinoma, Renal CellNCT00113529Pfizer42